Tag Archives: alzheimers

High-profile Biogen ads hype early Alzheimer’s detection as hospitals reject Aduhelm prescriptions

How do you sell an Alzheimer’s treatment mired in controversy over its disputed benefits? Biogen is turning to “Jim and Jane” for help.  That’s the couple grappling with the memory-robbing disease that Biogen and Japanese partner Eisai have placed at the center of their new marketing campaign, “It’s Time We Know.” The campaign is designed… Read More »

Patient receives first infusion of Biogen’s controversial Alzheimer’s drug

The exterior of the headquarters of biotechnology company Biogen in Cambridge, MA is pictured on March 21, 2019. John Tlumacki | Boston Globe | Getty Images A 70-year-old man from Rhode Island on Wednesday was the first person to receive an infusion of Biogen‘s newly approved Alzheimer’s drug, Aduhelm, outside of a clinical trial. Marc… Read More »

Dementia expert says evidence behind Biogen Alzheimer’s drug ‘wasn’t sufficient’ for FDA approval

Dementia expert Dr. Jason Karlawish told CNBC he’s skeptical of the Food and Drug Administration’s approval of Biogen‘s Alzheimer’s disease drug, Aduhelm, saying “the evidence to approve the drug wasn’t sufficient.” “Another study is needed to establish whether this drug, in fact, is effective. Unfortunately, the FDA approved the drug for marketing, although they also… Read More »

Canadian study fuels theory that Alzheimer’s is auto-immune disorder, opening new treatment options

Breadcrumb Trail Links News Health and Wellness Health Canada Using sophisticated lab techniques, the team found strong evidence in Alzheimer’s sufferers of several ‘autoantibodies’ that bind to brain-specific proteins Author of the article: Tom Blackwell Publishing date: May 14, 2021  •  2 days ago  •  4 minute read  •  54 Comments Finding a treatment for Alzheimer’s… Read More »